PMID- 10081102
OWN - NLM
STAT- MEDLINE
DCOM- 19990611
LR  - 20191103
IS  - 0340-2592 (Print)
IS  - 0340-2592 (Linking)
VI  - 38
IP  - 1
DP  - 1999 Jan
TI  - [Immunotesting--a conditio sine qua non for therapeutic BCG instillation in 
      bladder neck carcinoma?].
PG  - 51-4; discussion 54-5
AB  - The intravesical instillation of BCG (Bacillus Calmette-Guerin) in cases of 
      relapsed superficial bladder cancer is an acknowledged kind of prophylaxis. It is 
      uncertainly up to now whether a verification of the immune systems competence is 
      necessary. The recommendations in this problem are very different. In conclusion 
      to the recent literature we think that a verification of the immune system before 
      BCG installation in the urinary bladder has not a prognostic value. Additionally, 
      the legal obligingness of this immunotest is doubtful.
FAU - Werner, W
AU  - Werner W
AD  - Urologische Klinik, Friedrich-Schiller-Universitat Jena.
FAU - Wunderlich, H
AU  - Wunderlich H
FAU - Markert, U
AU  - Markert U
FAU - Schubert, J
AU  - Schubert J
LA  - ger
PT  - English Abstract
PT  - Journal Article
TT  - Immuntestung--eine Conditio sine qua non vor therapeutischer BCG-Instillation 
      beim Harnblasenkarzinom?
PL  - Germany
TA  - Urologe A
JT  - Der Urologe. Ausg. A
JID - 1304110
RN  - 0 (BCG Vaccine)
SB  - IM
MH  - Administration, Intravesical
MH  - BCG Vaccine/*administration & dosage/adverse effects/immunology
MH  - Humans
MH  - Immunocompetence/immunology
MH  - Malpractice/legislation & jurisprudence
MH  - Neoplasm Recurrence, Local/immunology/therapy
MH  - Prognosis
MH  - Risk Factors
MH  - *Tuberculin Test
MH  - Urinary Bladder Neoplasms/immunology/*therapy
EDAT- 1999/03/19 00:00
MHDA- 1999/03/19 00:01
CRDT- 1999/03/19 00:00
PHST- 1999/03/19 00:00 [pubmed]
PHST- 1999/03/19 00:01 [medline]
PHST- 1999/03/19 00:00 [entrez]
AID - 10.1007/s001200050245 [doi]
PST - ppublish
SO  - Urologe A. 1999 Jan;38(1):51-4; discussion 54-5. doi: 10.1007/s001200050245.